{[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]octane-1-carbonyl]-amino}-acetic acid methyl ester

ID: ALA424908

PubChem CID: 11995557

Max Phase: Preclinical

Molecular Formula: C23H33N5O5

Molecular Weight: 459.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCn1c(=O)c2nc([C@]34CC[C@](C(=O)NCC(=O)OC)(CC3)CC4)[nH]c2n(CCC)c1=O

Standard InChI:  InChI=1S/C23H33N5O5/c1-4-12-27-17-16(18(30)28(13-5-2)21(27)32)25-19(26-17)22-6-9-23(10-7-22,11-8-22)20(31)24-14-15(29)33-3/h4-14H2,1-3H3,(H,24,31)(H,25,26)/t22-,23+

Standard InChI Key:  ZAPNHSIRIXRZCP-ZRZAMGCNSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  1  0  0  0  0  0999 V2000
    7.7875  -10.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7875  -11.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2115  -11.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2115  -10.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4995   -9.9333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4991  -12.4086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8317  -12.8935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1665  -12.8935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9117  -13.6782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0855  -13.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6756  -14.3911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0872  -15.1067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9133  -15.1058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3279  -14.3892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6745  -15.8211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1529  -14.3871    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8506  -14.3909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4382  -13.6764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6132  -13.6762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3260  -15.8202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1510  -15.8200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5633  -15.1055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4976   -9.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2121   -8.6947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7832   -8.6947    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9042  -10.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2292  -10.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4958  -11.5833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9266   -9.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6410   -8.6947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3579   -9.1052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6435   -7.8677    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0709   -8.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 15  2  0
  1  5  1  0
 14 16  2  0
  7 10  1  0
 11 17  1  0
  9  8  1  0
 17 18  1  0
  8  6  2  0
 18 19  1  0
 28  6  1  1
 13 20  1  0
  9 10  2  0
 20 21  1  0
  2 28  1  0
 21 22  1  0
 28  3  1  0
  3  4  1  0
  4  5  1  0
 23 24  1  0
 23 25  2  0
  5 23  1  1
  6  7  1  0
  5 26  1  0
  1  2  1  0
 27 26  1  0
  9 14  1  0
 28 27  1  0
 10 11  1  0
 24 29  1  0
 11 12  1  0
 29 30  1  0
 12 13  1  0
 13 14  1  0
 30 31  1  0
 30 32  2  0
 31 33  1  0
M  END

Associated Targets(Human)

ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A2a (250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A2b (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.55Molecular Weight (Monoisotopic): 459.2482AlogP: 1.59#Rotatable Bonds: 8
Polar Surface Area: 128.08Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.43CX Basic pKa: 2.47CX LogP: 2.10CX LogD: 2.06
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.58Np Likeness Score: -0.52

References

1. Kiesman WF, Zhao J, Conlon PR, Dowling JE, Petter RC, Lutterodt F, Jin X, Smits G, Fure M, Jayaraj A, Kim J, Sullivan G, Linden J..  (2006)  Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.,  49  (24): [PMID:17125264] [10.1021/jm0605381]

Source